FI894899A0 - Menetelmä dispergoituvan kiinteän lääkeainekoostumuksen valmistamiseksi - Google Patents

Menetelmä dispergoituvan kiinteän lääkeainekoostumuksen valmistamiseksi

Info

Publication number
FI894899A0
FI894899A0 FI894899A FI894899A FI894899A0 FI 894899 A0 FI894899 A0 FI 894899A0 FI 894899 A FI894899 A FI 894899A FI 894899 A FI894899 A FI 894899A FI 894899 A0 FI894899 A0 FI 894899A0
Authority
FI
Finland
Prior art keywords
solid drug
preparing
dispersible solid
drug composition
dispersible
Prior art date
Application number
FI894899A
Other languages
English (en)
Swedish (sv)
Other versions
FI94925C (fi
FI94925B (fi
Inventor
Lorraine Mary Murphy
Graham Paul Matthews
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of FI894899A0 publication Critical patent/FI894899A0/fi
Application granted granted Critical
Publication of FI94925B publication Critical patent/FI94925B/fi
Publication of FI94925C publication Critical patent/FI94925C/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
FI894899A 1988-10-18 1989-10-16 Menetelmä dispergoituvan kiinteän lääkeainekoostumuksen valmistamiseksi FI94925C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8824392 1988-10-18
GB888824392A GB8824392D0 (en) 1988-10-18 1988-10-18 Dispersible formulation

Publications (3)

Publication Number Publication Date
FI894899A0 true FI894899A0 (fi) 1989-10-16
FI94925B FI94925B (fi) 1995-08-15
FI94925C FI94925C (fi) 1995-11-27

Family

ID=10645384

Family Applications (1)

Application Number Title Priority Date Filing Date
FI894899A FI94925C (fi) 1988-10-18 1989-10-16 Menetelmä dispergoituvan kiinteän lääkeainekoostumuksen valmistamiseksi

Country Status (19)

Country Link
EP (1) EP0365480B1 (fi)
JP (1) JP2795924B2 (fi)
KR (1) KR0151131B1 (fi)
AT (1) ATE79538T1 (fi)
AU (1) AU626924B2 (fi)
CA (1) CA2000763C (fi)
DE (1) DE68902531T2 (fi)
DK (1) DK170793B1 (fi)
ES (1) ES2052065T3 (fi)
FI (1) FI94925C (fi)
GB (1) GB8824392D0 (fi)
GR (1) GR3006304T3 (fi)
IE (1) IE62557B1 (fi)
IL (1) IL91949A (fi)
NZ (1) NZ231023A (fi)
PH (1) PH30526A (fi)
PT (1) PT92002B (fi)
SA (1) SA90100079B1 (fi)
ZA (1) ZA897853B (fi)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2059260B1 (es) 1992-10-06 1995-04-16 Espanola Prod Quimicos Procedimiento de preparacion de comprimidos conteniendo diclofenaco; dispersables en agua.
DE4403943A1 (de) 1994-02-08 1995-08-10 Hexal Pharma Gmbh Orale Azrneimittelzubereitung mit Diclofenac-Natrium
ES2082723B1 (es) * 1994-07-20 1996-10-01 Lilly Sa Formulacion farmaceutica de fluoxetina en forma dispersable.
JP3797387B2 (ja) * 1996-06-14 2006-07-19 協和醗酵工業株式会社 口腔内速崩壊錠
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
EP0839526A3 (en) 1996-10-31 1999-01-07 Takeda Chemical Industries, Ltd. Solid pharmaceutical preparation with fast buccal disintegration or dissolution
US6312724B1 (en) 1997-04-04 2001-11-06 Isa Odidi Sustained release pharmaceutical matrix tablet of pharmaceutically acceptable salts of diclofenac and process for preparation thereof
CN1195500C (zh) 1998-05-18 2005-04-06 武田药品工业株式会社 可口腔崩解的片剂
EP1083885B1 (en) * 1998-06-11 2006-12-27 Pharmacia & Upjohn Company LLC Delavirdine tablet formulation
SI1100469T1 (fi) 1998-07-28 2005-08-31 Takeda Pharmaceutical
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
DE10351448A1 (de) * 2003-11-04 2005-06-09 Bayer Healthcare Ag Geschmackstoffhaltige Arzneimittelformulierungen mit verbesserten pharmazeutischen Eigenschaften
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
EP1802285B1 (en) 2004-10-21 2013-02-27 Aptalis Pharmatech, Inc. Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
JO3352B1 (ar) 2005-06-17 2019-03-13 Apr Applied Pharma Res Sa صيغ دايكلوفيناك وطرق استخدامه
UA97813C2 (uk) * 2006-12-05 2012-03-26 Янссен Фармацевтика Н.В. Фумаратна сіль (альфа s, бета r)-6-бром-альфа-[2-(диметиламіно)етил]-2-метоксі-альфа-1-нафталеніл-бета-феніл-3-хінолінетанолу
TW201113266A (en) * 2009-09-02 2011-04-16 Ziopharm Oncology Inc Pharmaceutical formulations for indibulin
TWI471146B (zh) 2009-12-02 2015-02-01 Aptalis Pharma Ltd 菲索特芬那定(fexofenadine)微膠囊及包含其之組合物
WO2013156163A1 (en) 2012-04-19 2013-10-24 Glatt Ag Taste-masked pharmaceutical compositions containing diclofenac
DE202022100544U1 (de) 2022-01-31 2022-02-16 Ranjitsing Babasing Bayas Neue orale Streifen- oder Dünnfilmform von Diclofenac-Natrium

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1200178B (it) 1986-07-23 1989-01-05 Alfa Farmaceutici Spa Formulazioni galeniche a cessione programmata contenenti farmaci ad attivita' antiflogistica
IT1215726B (it) * 1988-01-18 1990-02-22 Alfa Wassermann Spa Formulazioni galeniche a cessione programmata.
CH675537A5 (fi) * 1988-03-25 1990-10-15 Ciba Geigy Ag

Also Published As

Publication number Publication date
SA90100079B1 (ar) 1999-03-21
IE893336L (en) 1990-04-18
NZ231023A (en) 1991-09-25
GB8824392D0 (en) 1988-11-23
PT92002A (pt) 1990-04-30
DE68902531T2 (de) 1993-04-08
KR900005964A (ko) 1990-05-07
FI94925C (fi) 1995-11-27
EP0365480A1 (en) 1990-04-25
ZA897853B (en) 1992-07-29
IE62557B1 (en) 1995-02-08
DK170793B1 (da) 1996-01-22
DE68902531D1 (de) 1992-09-24
FI94925B (fi) 1995-08-15
PT92002B (pt) 1995-06-30
EP0365480B1 (en) 1992-08-19
PH30526A (en) 1997-06-13
DK515489D0 (da) 1989-10-17
DK515489A (da) 1990-04-19
AU626924B2 (en) 1992-08-13
KR0151131B1 (ko) 1998-10-15
JP2795924B2 (ja) 1998-09-10
AU4297089A (en) 1990-04-26
IL91949A0 (en) 1990-06-10
IL91949A (en) 1993-08-18
ES2052065T3 (es) 1994-07-01
CA2000763C (en) 2000-11-14
GR3006304T3 (fi) 1993-06-21
JPH02164824A (ja) 1990-06-25
CA2000763A1 (en) 1990-04-18
ATE79538T1 (de) 1992-09-15

Similar Documents

Publication Publication Date Title
FI894899A0 (fi) Menetelmä dispergoituvan kiinteän lääkeainekoostumuksen valmistamiseksi
FI872864A (fi) Menetelmä farmaseuttisesti aktiivisten bentsimidatsolijohdannaisten valmistamiseksi
HU901627D0 (en) Process for the preparation of novel n-(3-hydroxy-4-piperidinyl)-dihydrobenzofurane-,-dihydro-2h-benzopyrane- and -dihydro-benzo-dioxy-carboxamide derivatives and pharmaceutical compositions containing them
DK0495982T3 (da) Bicyklisk pyrimidinderivat, fremgangsmåde til fremstilling deraf og farmaceutisk præparat omfattende dette som en aktiv bestanddel
EP0151824A3 (en) N-(4-piperidinyl) bicyclic condesed 2-imidazolamine derivatives
ZA928170B (en) Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of alpha-D-neuraminic acid
FI943687A (fi) Uudet 11-bentsaldoksiimiestradieenijohdannaiset, menetelmät niiden valmistamiseksi ja näitä yhdisteitä sisältävät lääkeaineet
HUT48589A (en) Process for production of new derivatives of substituated n-/1-hydroxi-4-piperidinil/-benzamid
ATE121949T1 (de) 5,10-methylentetrahydrofolsäure-cyclodextrin- einschlussverbindungen.
NO176051C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 3-piperazinylbenzazol-derivater
NO167737C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tetrahydroimidazo(1,4)benzodiazepin-2-oner.
GR3004863T3 (fi)
PL286188A1 (en) Method of obtaining renine retarding aminooligohydroxy derivatives
IT1247508B (it) Composizioni farmaceutiche contenenti l'estere 4-(2 metilamminoetil)- 1,2- fenilenicodell`acido 2-metilpropanoico per il trattamento della neurootticopatia glaucomatosa
ZA933942B (en) Pyrrolothienopyrazine compounds, processes for the preparation thereof and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
BB Publication of examined application
PC Transfer of assignment of patent

Owner name: NOVARTIS AG

FG Patent granted

Owner name: NOVARTIS AG